COPLAND ROAD CAPITAL NEW - Asset Resilience Ratio

Latest as of September 2025: 0.00%

COPLAND ROAD CAPITAL NEW (A2P) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€1.31K

≈ $1.54K USD Cash + Short-term Investments

Total Assets

€489.11 Million

≈ $571.82 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how COPLAND ROAD CAPITAL NEW's Asset Resilience Ratio has changed over time. See COPLAND ROAD CAPITAL NEW (A2P) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down COPLAND ROAD CAPITAL NEW's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see A2P stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.31K	0.0%
Total Liquid Assets	€1.31K	0.00%

Asset Resilience Insights

Limited Liquidity: COPLAND ROAD CAPITAL NEW maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

COPLAND ROAD CAPITAL NEW Industry Peers by Asset Resilience Ratio

Compare COPLAND ROAD CAPITAL NEW's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for COPLAND ROAD CAPITAL NEW (2022–2025)

The table below shows the annual Asset Resilience Ratio data for COPLAND ROAD CAPITAL NEW.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	€1.31K ≈ $1.54K	€489.11 Million ≈ $571.82 Million	-0.27pp
2023-12-31	0.27%	€802.49K ≈ $938.19K	€299.92 Million ≈ $350.63 Million	-0.23pp
2022-12-31	0.50%	€1.18 Million ≈ $1.38 Million	€236.48 Million ≈ $276.47 Million	--

pp = percentage points

About COPLAND ROAD CAPITAL NEW

F:A2P Germany Medical Devices

Market Cap

$836.60 Million

€715.59 Million EUR

Market Cap Rank

#11214 Global

#1285 in Germany

Share Price

€83.90

Change (1 day)

+0.36%

52-Week Range

€48.00 - €91.05

All Time High

€91.05